Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Jul 31, 2026
WEX Inc. (WEX) Stock Climbs +30.7% on Q2 Beat and Raised 2026 Guidance

WEX Inc. (WEX) Stock Climbs +30.7% on Q2 Beat and Raised 2026 Guidance

Key Takeaways

  • WEX shares surged approximately 30.7% over the past 30 days, climbing from $142.59 on July 1 to $186.40 by July 30, 2026.
  • A standout Q2 2026 earnings report on July 22 drove the bulk of gains, with revenue of $753.5 million and adjusted EPS of $5.35 handily beating analyst estimates.
  • Management raised full-year 2026 guidance, now projecting revenue of $2.86 billion to $2.90 billion and adjusted EPS of $19.68 to $20.08.
  • Elevated fuel prices provided a significant revenue tailwind for the Mobility segment, while the company's AI-powered SecureFuel fraud prevention tool added a growth narrative.
  • Share repurchases totaling approximately $93 million from May through July 20 signaled management confidence and supported the stock's upward momentum.
  • Over the broader quarter, WEX experienced a sharp V-shaped recovery after hitting a mid-June low near $126.86, reflecting improved sentiment and operational execution.

WEX Inc. (WEX) Business and Market Position

WEX Inc. is a global leader in intelligent payment solutions, operating across three core segments: Mobility, Corporate Payments, and Health and Employee Benefits. The Mobility division provides fuel cards, fleet management, and payment processing to more than 600,000 commercial fleet customers worldwide. The Corporate Payments segment delivers business-to-business payment solutions, including virtual cards and embedded payments, while the Benefits segment administers health savings accounts (HSAs), flexible spending accounts (FSAs), and COBRA services, with average HSA custodial cash assets exceeding $5.2 billion. Headquartered in Portland, Maine, WEX processes over $68 billion in total quarterly volume across its platform and competes in the increasingly digitized payments ecosystem against both legacy processors and emerging fintech challengers.

Stock Performance: +30.7% Surge Over 30 Days

Over the past 30 days, WEX stock posted a remarkable gain of approximately 30.7%, advancing from a closing price of $142.59 on July 1, 2026, to $186.40 on July 30. The rally accelerated sharply following the company's July 22 earnings release, with shares jumping from $155.68 to $171.47 in a single session and continuing their climb through month-end. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

The broader quarterly picture reveals a dramatic recovery. WEX entered the second quarter near $150 and rallied to an April high of $184.93 before a sharp selloff sent shares tumbling to a multi-month trough of $126.86 by June 17. The stock clawed back to $141.09 by June 30, setting the stage for July's powerful rally. Measured from late April, the stock has climbed roughly 24%, but the path was anything but linear, marked by significant volatility that tested investor conviction before the eventual recovery took hold.

Q2 Earnings and Guidance Raise Drive Momentum

The primary catalyst during the past 30 days was WEX's Q2 2026 earnings report released on July 22. The company posted revenue of $753.5 million, a 14.2% year-over-year increase and comfortably above the consensus estimate of approximately $738 million. Adjusted earnings per share reached $5.35, surging 35.4% compared to the prior-year period and exceeding analyst forecasts of $5.06. GAAP net income per diluted share of $3.11 represented a 57.1% year-over-year improvement.

Fuel prices played an outsized role in the quarter's outperformance. U.S. diesel prices rose roughly 27% during 2026, contributing approximately $63.8 million in incremental revenue and $1.01 to adjusted EPS. Critically, however, even after stripping out fuel price and foreign exchange effects, WEX delivered 4.2% organic revenue growth and 10.1% organic adjusted EPS growth, confirming genuine underlying business momentum.

Management raised full-year guidance on the back of these results, lifting the revenue midpoint to approximately $2.88 billion and adjusted EPS to around $19.88. The company also announced it had repurchased roughly $93 million in shares between May and July 20, reinforcing a capital-return posture that resonated with investors. Additionally, the launch of SecureFuel, an AI-powered fraud prevention tool for fleet customers, provided a forward-looking technology narrative that contributed to positive sentiment around WEX's innovation trajectory.

Quarterly V-Shaped Recovery and Broader Context

WEX's quarterly journey was defined by two distinct phases: a punishing selloff from late April through mid-June, followed by a sharp recovery. The downturn reflected broader macroeconomic concerns, including uncertainty around freight markets, competitive pressures in the middle-market segment, and the seasonal step-down in the Benefits business. Shares bottomed at $126.86 on June 17, representing a decline of more than 31% from the April peak.

The recovery that followed gained traction as fuel prices remained elevated and the freight market showed tentative signs of stabilization — what Morgan Stanley analysts described as "green shoots." The May announcement of a $1 billion share repurchase program provided a floor for the stock, while successive analyst actions, including a Morgan Stanley price target increase to $172, signaled improving Street sentiment heading into earnings. By late July, the combination of a clean earnings beat, upgraded guidance, and visible capital returns had not only erased the quarterly drawdown but propelled the stock to levels not seen since April.

Forward Outlook and Factors to Watch

Looking ahead, several factors will shape WEX's trajectory. Third-quarter guidance calling for revenue of $733 million to $753 million and adjusted EPS of $5.45 to $5.65 sets a high bar that investors will measure against actual results. Fuel price dynamics remain a double-edged sword — while elevated prices boost Mobility revenue, any reversal could pressure top-line growth and force guidance revisions.

The Corporate Payments segment's embedded payments and AP Direct offerings are expected to sustain mid-teens growth, and management's pricing actions in Mobility are projected to add approximately $15 million in second-half revenue. On the macro front, the trajectory of freight markets, interest rate policy, and geopolitical risks affecting fuel supply will influence volumes and sentiment. WEX's ability to expand margins through AI-driven operational efficiencies — already cited as contributing to headcount reduction amid revenue growth — represents an additional lever that analysts and investors will monitor closely through year-end.

AI Tools in My Research Process

When evaluating stocks with complex drivers like fuel prices and segment-specific growth, I often reference Tickeron's Trending AI Robots to explore automated strategies that align with current market conditions. This resource highlights top-performing bots across equities and other assets, helping me cross-check sentiment and identify complementary approaches without replacing core fundamental analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: WEX

WEX in upward trend: 10-day moving average moved above 50-day moving average on July 09, 2026

The 10-day moving average for WEX crossed bullishly above the 50-day moving average on July 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for WEX moved above the 200-day moving average on August 06, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WEX advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 295 cases where WEX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where WEX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for WEX turned negative on August 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WEX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

WEX broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.792) is normal, around the industry mean (24.057). P/E Ratio (18.868) is within average values for comparable stocks, (74.273). Projected Growth (PEG Ratio) (1.057) is also within normal values, averaging (1.911). WEX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.021). P/S Ratio (2.367) is also within normal values, averaging (134.061).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. WEX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), Twilio (NYSE:TWLO), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.26B. The market cap for tickers in the group ranges from 48.8K to 3.74T. MSFT holds the highest valuation in this group at 3.74T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 2%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 25%. AIFA experienced the highest price growth at 94%, while GYGY experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 72
Price Growth Rating: 56
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
WEX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of payment processing and information management services

Industry ComputerCommunications

Profile
Details
Industry
Data Processing Services
Address
1 Hancock Street
Phone
+1 207 773-8171
Employees
7200
Web
https://www.wexinc.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.